Breathe-Easy: Hayfever Care for Patients With Seasonal Allergic Rhinitis
Not Applicable
Completed
- Conditions
- HayfeverAllergy PollenAllergic Rhinitis
- Registration Number
- NCT06765239
- Lead Sponsor
- Innowage Limited
- Brief Summary
This waitlist-controlled trial aims to evaluate the therapeutic effectiveness of Hayfever Care by assessing disease-specific symptoms over a 4-week period. Additionally, the study examines the tolerability and safety of the solution.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 63
Inclusion Criteria
- Mild to moderate symptoms during the hayfever season
- Generally healthy individuals without chronic illnesses
- Willingness to comply with study requirements, including completing symptom diaries.
Exclusion Criteria
- History of anaphylaxis or severe hayfever symptoms requiring emergency treatment.
- Pregnant or breastfeeding
- History of substance abuse or excessive alcohol consumption.
- Use of systemic corticosteroids, immunotherapy
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Well-being Numerical Rating Scales Change from Baseline to 4 weeks after baseline
- Secondary Outcome Measures
Name Time Method Change of Symptom Dry Eyes Change in symptom scores from baseline to 4 weeks. Change of Symptom Itching Eyes Change in symptom scores from baseline to 4 weeks. Change of Symptom Burning Eyes Change in symptom scores from baseline to 4 weeks. Change of Symptom Respiratory Complaints Change in symptom scores from baseline to 4 weeks. Change of Symptom Sneezing Change in symptom scores from baseline to 4 weeks. Change of Symptom Rhinitis Change in symptom scores from baseline to 4 weeks. Change of Symptom Fatigue Change in symptom scores from baseline to 4 weeks. Change of Symptom Headache Change in symptom scores from baseline to 4 weeks.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular targets does Breathe-Easy Hayfever Care modulate in seasonal allergic rhinitis pathophysiology?
How does Breathe-Easy Hayfever Care compare to antihistamines/corticosteroids in allergic rhinitis symptom control?
Which biomarkers predict response to Breathe-Easy Hayfever Care in Th2-driven allergic rhinitis subtypes?
What are the safety profiles and adverse event management strategies for Breathe-Easy Hayfever Care nasal solution?
Are there combination therapies or competitor drugs for seasonal allergic rhinitis similar to Breathe-Easy Hayfever Care?
Trial Locations
- Locations (1)
Gyansanjeevani India
🇮🇳Jaipur, Rajasthan, India